Explore more publications!
Florida Health Daily
Got News to Share?

Florida Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

Press releases published on January 28, 2026

Jupiter Neurosciences Expands Nugevia™ Addressable Market with Focus on GLP-1 Users
Jan. 28, 2026

Jupiter Neurosciences Expands Nugevia™ Addressable Market with Focus on GLP-1 Users

Indeterminate EIN Presswire
Identifyn® LLC ANNOUNCES COMPLETION OF ANTIBODY VALIDATION IN FLOW CYTOMETRY
Jan. 28, 2026

Identifyn® LLC ANNOUNCES COMPLETION OF ANTIBODY VALIDATION IN FLOW CYTOMETRY

Indeterminate EIN Presswire
Headsafe Enters U.S. Healthcare Market with FDA-Cleared Concussion Assessment Device
Jan. 28, 2026

Headsafe Enters U.S. Healthcare Market with FDA-Cleared Concussion Assessment Device

Indeterminate EIN Presswire
NATIONAL SPACE SOCIETY SPACE BUSINESS COMPETITION CLOSES ON FEBRUARY 15
Jan. 28, 2026

NATIONAL SPACE SOCIETY SPACE BUSINESS COMPETITION CLOSES ON FEBRUARY 15

Indeterminate EIN Presswire
Optigy Announces Acquisition of TempMD
Jan. 28, 2026

Optigy Announces Acquisition of TempMD

Indeterminate EIN Presswire
Ryoncil® Net Revenues Increase for the Quarter to US$30M
Jan. 28, 2026

Ryoncil® Net Revenues Increase for the Quarter to US$30M

Indeterminate GlobeNewswire
Psyence BioMed Announces Effective Date for 1-for-6.25 Reverse Stock Split
Jan. 28, 2026

Psyence BioMed Announces Effective Date for 1-for-6.25 Reverse Stock Split

Indeterminate GlobeNewswire
TomorrowsRx Telehealth Service Outlines Prescription Access for Compounded Semaglutide and Advanced Tirzepatide Formulations
Jan. 28, 2026

TomorrowsRx Telehealth Service Outlines Prescription Access for Compounded Semaglutide and Advanced Tirzepatide Formulations

Indeterminate GlobeNewswire
Elevar Therapeutics Submits New Drug Application to FDA for Lirafugratinib as Second-Line Treatment Option for Cholangiocarcinoma
Jan. 28, 2026

Elevar Therapeutics Submits New Drug Application to FDA for Lirafugratinib as Second-Line Treatment Option for Cholangiocarcinoma

Indeterminate GlobeNewswire
MEDVI Quad Prescription Information Updated as Consumer Interest in Prescription Erectile Dysfunction Treatment Access Through Telehealth Platforms Grows in 2026
Jan. 28, 2026

MEDVI Quad Prescription Information Updated as Consumer Interest in Prescription Erectile Dysfunction Treatment Access Through Telehealth Platforms Grows in 2026

Indeterminate GlobeNewswire
STERIS Announces Dividend of $0.63 per share
Jan. 28, 2026

STERIS Announces Dividend of $0.63 per share

Indeterminate GlobeNewswire
Future Communities Institute, with Akido Labs, Five Keys, and ReImagine Freedom Launch the Bay Area’s First AI-Powered Safety Net Program
Jan. 28, 2026

Future Communities Institute, with Akido Labs, Five Keys, and ReImagine Freedom Launch the Bay Area’s First AI-Powered Safety Net Program

Indeterminate GlobeNewswire
Park Dental Partners Expands Presence in Arizona with Addition of Ironwood Dental
Jan. 28, 2026

Park Dental Partners Expands Presence in Arizona with Addition of Ironwood Dental

Indeterminate GlobeNewswire
Serina Therapeutics Announces FDA Clearance of IND Application for SER-252 for the Treatment of Advanced Parkinson’s disease
Jan. 28, 2026

Serina Therapeutics Announces FDA Clearance of IND Application for SER-252 for the Treatment of Advanced Parkinson’s disease

Indeterminate GlobeNewswire
Kalaris to Present Phase 1 Clinical Data for TH103 at the Macula Society Annual Meeting
Jan. 28, 2026

Kalaris to Present Phase 1 Clinical Data for TH103 at the Macula Society Annual Meeting

Indeterminate GlobeNewswire
Amneal Pharmaceuticals Added to S&P SmallCap 600® Index
Jan. 28, 2026

Amneal Pharmaceuticals Added to S&P SmallCap 600® Index

Indeterminate GlobeNewswire
Senseonics Holdings, Inc. to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Jan. 28, 2026

Senseonics Holdings, Inc. to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Indeterminate GlobeNewswire
University of Virginia Signs Master Research Collaboration Agreement with AstraZeneca to Accelerate Pre-Clinical Innovation
Jan. 28, 2026

University of Virginia Signs Master Research Collaboration Agreement with AstraZeneca to Accelerate Pre-Clinical Innovation

Indeterminate GlobeNewswire
Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides a Corporate Update
Jan. 28, 2026

Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides a Corporate Update

Indeterminate GlobeNewswire
Women’s Health Collective Canada Announces Vital Talks Event on Menstruation and Lifelong Hormonal Health, Presented by Vichy Laboratoires
Jan. 28, 2026

Women’s Health Collective Canada Announces Vital Talks Event on Menstruation and Lifelong Hormonal Health, Presented by Vichy Laboratoires

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions